Breaking Down Biologics in Atopic Dermatitis: Choosing the Right Path for Patients - Episode 2
Panelists discuss how establishing realistic treatment goals for patients with moderate to severe atopic dermatitis requires collaborative conversations addressing itch reduction, sleep improvement, and quality-of-life enhancement, whereas decisions to initiate systemic therapy are driven by inadequate response to optimized topical regimens, disease impact on daily functioning, recurrent flares, significant psychological burden, treatment adherence challenges, and the recognition that early intervention may prevent disease progression and comorbidities.
Video content above is prompted by the following: